Ambu AS (STU:547A)
€ 15.73 -1.58 (-9.13%) Market Cap: 4.19 Bil Enterprise Value: 4.18 Bil PE Ratio: 75.98 PB Ratio: 6.11 GF Score: 90/100

Ambu A/S Corporate Analyst Meeting Transcript

Mar 21, 2023 / 09:00AM GMT
Release Date Price: €13.62 (-0.95%)
Britt Meelby Jensen;S;CEO
Ambu A

/-

So good morning, everyone. And welcome to this Ambu Capital Market Day, March 2023. It has been almost 4 years since we last hosted an event like this. So we have been looking very much forward. For Ambu, we see a future full of potential. We think we are strongly positioned as a business to deliver on that potential, and we hope to convince you about the same during today.

So I know most of you know our business very well. You also know the products we bring to the market. But let me just kick this meeting off by telling you what is the everyday life of our customers, hospitals and clinics when they do endoscopy.

So every year, 200 million people in the world go through an endoscopy procedure, either as a simple check for cancer or as a more specialized procedure. This is a fact. But what's not so commonly used is that this involves a lot of complexity. And let me walk you through some of the steps of what actually happens when an endoscopy procedure is done. So first, the physician has to go and get a clean and well

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot